´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (1ÀÏÂ÷) : 2024-04-11
±³À°ÀÏÀÚ : 2024-04-11
±³À°Àå¼Ò : ÀüÁÖ ¶óÇÑÈ£ÅÚ, ¿Â°íÀ»È¦(1F)
±³À°ÁÖÁ¦ : ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ&Á¦21Â÷ °ü»óµ¿¸Æ¿Ü°úÇÐȸ Çмú½ÉÆ÷Áö¿ò (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ(21.11.10 ¸íĪº¯°æ ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : °ü»óµ¿¸Æ¿Ü°úÇÐȸ
´ã´çÀÚ : ÇÑÈñ¼ö
¿¬¶ôó : 02-6002-1382
À̸ÞÀÏ : hhs@ghkh.co.kr
±³À°Á¾·ù : ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í "°ü»óµ¿¸Æ¿Ü°úÇÐȸ Á¤È¸¿ø : »çÀüµî·Ï ¹«·á / ÇöÀåµî·Ï 8¸¸¿ø
Àü¹®ÀÇ : »çÀüµî·Ï 12¸¸¿ø/ ÇöÀå 15¸¸¿ø
Àü°øÀÇ, °£È£»ç, ü¿Ü¼øȯ»ç , ±×¿Ü °ü°èÀÚ : »çÀü 8¸¸¿ø/ ÇöÀå 10¸¸¿ø
Çлý : »çÀü ¹«·á/ ÇöÀå ¹«·á
´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ ¿ø·Îȸ¿ø: »çÀü ¹«·á/ ÇöÀå ¹«·á"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 10:10~10:25 Importance of thyroid function test in CABG patients ¹Ú¿µÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 10:25~10:40 Update in perioperative glucose management in CABG patients ÀÌ°æ¾Ö(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 10:40~10:55 Adjunctive drugs for CABG patients; NO drugs, trimetazidine and beyonds ±èÀ̽Ä(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 10:55~11:10 Update in prevention and treatment of postoperative atrial fibrillation after CABG ÁÖ¹ÎÈ£(ºÎ»êÀÇ´ë)
Åä·Ð 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 11:10~11:30 Discussion All Speakers()
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 11:50~12:10 °ü»óµ¿¸Æ¿ìȸ·Î¼ú ÀûÁ¤¼ºÆò°¡ÀÇ ÇöȲ ¹× °³¼±¹æ¾È - °Ç°º¸Çè½É»çÆò°¡¿øÀÇ ÀÔÀå ±èÁöÇý(°Ç°º¸Çè½É»çÆò°¡¿ø Æò°¡ºÎÀå)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 12:10~12:20 °ü»óµ¿¸Æ¿ìȸ·Î¼ú ÀûÁ¤¼ºÆò°¡ÀÇ °³¼±¹æ¾È - ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú ÀÇ»çÀÇ ÀÔÀå ¿°»óÀ±(ºÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 12:20~12:30 °ü»óµ¿¸Æ¿ìȸ·Î¼ú µ¥ÀÌÅͺ£À̽º ¼Ò°³ ÁÖ¹ÎÈ£(ºÎ»êÀÇ´ë)
Åä·Ð 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 12:30~12:50 Panel discussion, Q&A È«¼øâ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 12:50~13:40 SGLT2-inhibitor - Jardiance ½Å´ëÈñ(ÀüÁÖ´ëÀÚÀκ´¿ø)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 13:50~14:05 Optimal assessment of the anastomosis in CABG using TTFM and ECUS Hirofumi Takemura(Kanazawa Univ.)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 14:05~14:20 Various application of conventional ultrasound in CABG ȲÁøÈ£(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 14:20~14:35 Impella-supported off-pump CABG for severe ischemic cardiomyopathy Hiroshi Niinami(Tokyo Women)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 14:35~14:50 ECMO-supported CABG for ischemic cardiomyopathy ±èÁؼº(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 14:50~15:10 Panel discussion ±èµµÁ¤, ±èÈ£Áø(¾ÆÁÖÀÇ´ë, ¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 15:30~15:45 Characteristics of SV and History of SV use in CABG ¿À¼¼Áø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 15:45~16:00 Current guidelines and Evidences of CABG using SV ÀÌÁØÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 16:00~16:15 Surgical strategy of SV harvesting / SV grafting À̱âÁ¾(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 16:15~16:30 Combating SV graft failure; current evidence ¼Õ¼®È£(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 16:30~16:50 Discussion All Speakers()
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 16:50~17:10 Surgical treatment of coronary-to-bronchial artery fistula ±èÁö¼º(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 17:10~17:30 Thromboangiitis Obliterans of Coronary and Internal Thoracic Arteries ±èÁÖ¿¬(ÀÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 04¿ù 11ÀÏ ¿Â°íÀ»È¦(1F) 17:30~17:50 Use of saphenous vein in adolescent patients °À±Áø(¼¿ïÀÇ´ë)